For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148$2,748/year on Semaglutide Injection, and $2,748$3,708/year on Tirzepatide Injection well below FDA-approved branded GLP-1s at retail list price (~$1,000$1,350/month before insurance)
This makes it easier to stick to a healthy diet and avoid overeating
Effect of liraglutide 3.0 mg cessation on efficacy and safety/tolerability after 56 weeks treatment in obese/overweight adults with type 2 diabetes: SCALE diabetes
Risk of bias using Cochrane risk-of-bias tool for randomized trials-Deandfield, 2024
10.1210/me.2004-0312 26 JorgensenR.Norklit RoedS.HedingA.EllingC